Allergan Goes After Apotex Over Combigan ANDA
Allergen filed suit Tuesday in the U.S. District Court for the Eastern District of Texas, claiming that the Canadian generics maker and its U.S. subsidiary Apotex Corp. infringed patents covering Combigan by submitting an abbreviated new drug application to manufacture their own version of brimonidine tartrate/ timolol maleate ophthalmic solution.
“The commercial manufacture, use, offer for...
Already a subscriber? Click here to login